These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2009213)

  • 1. Chimeric antibody: potential applications for drug delivery and immunotherapy.
    Shin SU
    Biotherapy; 1991; 3(1):43-53. PubMed ID: 2009213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically engineered (chimeric) antibodies.
    Morrison SL
    Hosp Pract (Off Ed); 1989 Oct; 24(10):65-9, 72-4, 77-80. PubMed ID: 2551912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfectomas provide novel chimeric antibodies.
    Morrison SL
    Science; 1985 Sep; 229(4719):1202-7. PubMed ID: 3929380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen.
    Sahagan BG; Dorai H; Saltzgaber-Muller J; Toneguzzo F; Guindon CA; Lilly SP; McDonald KW; Morrissey DV; Stone BA; Davis GL
    J Immunol; 1986 Aug; 137(3):1066-74. PubMed ID: 3088107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse/human chimeric Me1-14 antibody: genomic cloning of the variable region genes, linkage to human constant region genes, expression, and characterization.
    Batra SK; Niswonger ML; Wikstrand CJ; Pegram CN; Zalutsky MR; Morrison SL; Bigner DD
    Hybridoma; 1994 Apr; 13(2):87-97. PubMed ID: 8050781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a human T cell-specific chimeric antibody (CD7) with human constant and mouse variable regions.
    Heinrich G; Gram H; Kocher HP; Schreier MH; Ryffel B; Akbar A; Amlot PL; Janossy G
    J Immunol; 1989 Dec; 143(11):3589-97. PubMed ID: 2479683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and characterization of a functional chimeric murine-human antibody directed against human fibrin fragment-D dimer.
    Bulens F; Vandamme AM; Bernar H; Nelles L; Lijnen RH; Collen D
    Eur J Biochem; 1991 Jan; 195(1):235-42. PubMed ID: 1899382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.
    Morrison SL; Johnson MJ; Herzenberg LA; Oi VT
    Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6851-5. PubMed ID: 6436822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and expression of two mouse-human chimeric antibodies with high specificity and affinity for carcinoembryonic antigen.
    Arakawa F; Haruno M; Kuroki M; Kanda H; Watanabe T; Misumi Y; Matsuoka Y
    Hybridoma; 1993 Aug; 12(4):365-79. PubMed ID: 8244416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.
    LoBuglio AF; Wheeler RH; Trang J; Haynes A; Rogers K; Harvey EB; Sun L; Ghrayeb J; Khazaeli MB
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4220-4. PubMed ID: 2726771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and characterization of an antibody binding specificity joined to insulin-like growth factor 1: potential applications for cellular targeting.
    Shin SU; Morrison SL
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5322-6. PubMed ID: 2115168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen.
    Shaw DR; Khazaeli MB; Sun LK; Ghrayeb J; Daddona PE; McKinney S; LoBuglio AF
    J Immunol; 1987 Jun; 138(12):4534-8. PubMed ID: 3584980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
    Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
    Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric antibodies with 17-1A-derived variable and human constant regions.
    Sun LK; Curtis P; Rakowicz-Szulczynska E; Ghrayeb J; Morrison SL; Chang N; Koprowski H
    Hybridoma; 1986 Jul; 5 Suppl 1():S17-20. PubMed ID: 3744381
    [No Abstract]   [Full Text] [Related]  

  • 18. Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A.
    Sun LK; Curtis P; Rakowicz-Szulczynska E; Ghrayeb J; Chang N; Morrison SL; Koprowski H
    Proc Natl Acad Sci U S A; 1987 Jan; 84(1):214-8. PubMed ID: 3025856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency.
    Velders MP; Litvinov SV; Warnaar SO; Gorter A; Fleuren GJ; Zurawski VR; Coney LR
    Cancer Res; 1994 Apr; 54(7):1753-9. PubMed ID: 8137290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically engineered antibodies and their application to brain delivery.
    Morrison SL; Shin SU
    Adv Drug Deliv Rev; 1995 Jul; 15(1-3):147-175. PubMed ID: 35524387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.